![](/img/cover-not-exists.png)
O4 PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-α-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDVRNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY
Wedemeyer, H., Yurdaydin, C., Ernst, S., Caruntu, F.A., Curescu, M.G., Yalcin, K., Akarca, U.S., Gürel, S., Zeuzem, S., Erhardt, A., Lüth, S., Papatheodoridis, G.V., Keskin, O., Port, K., Radu, M., CeVolume:
60
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(14)60006-4
Date:
April, 2014
File:
PDF, 106 KB
english, 2014